Clinical Trial Update: Donidalorsen Expanded Access Program for Patients With Hereditary Angioedema

View source ↗

Summary

This update confirms an expanded access program for donidalorsen in patients with hereditary angioedema, allowing eligible patients to access the investigationa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Donidalorsen (antisense oligonucleotide targeting prekallikrein)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Hereditary Angioedema | Status: AVAILABLE